These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31798788)

  • 1. Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes.
    Korbut AI; Klimontov VV; Vinogradov IV; Romanov VV
    World J Diabetes; 2019 Nov; 10(11):517-533. PubMed ID: 31798788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. URINARY EXCRETION OF ALPHA-ACTININ-4 AND TIGHT JUNCTION PROTEIN 1 IN PATIENTS WITH TYPE 2 DIABETES AND DIFFERENT PATTERNS OF CHRONIC KIDNEY DISEASE.
    Korbut A; Romanov V; Klimontov V
    Georgian Med News; 2024 Mar; (348):72-77. PubMed ID: 38807395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
    Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
    Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex Bead Array Assay of a Panel of Circulating Cytokines and Growth Factors in Patients with Albuminuric and Non-AlbuminuricDiabetic Kidney Disease.
    Klimontov VV; Korbut AI; Orlov NB; Dashkin MV; Konenkov VI
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32961903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy.
    Fukuda A; Minakawa A; Kikuchi M; Sato Y; Nagatomo M; Nakamura S; Mizoguchi T; Fukunaga N; Shibata H; Naik AS; Wiggins RC; Fujimoto S
    Sci Rep; 2020 Oct; 10(1):18209. PubMed ID: 33097787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
    Di Marco M; Scilletta S; Miano N; Marrano N; Natalicchio A; Giorgino F; Di Mauro S; Filippello A; Scamporrino A; Tribulato P; Bosco G; Di Giacomo Barbagallo F; Scicali R; Milluzzo A; Ballirò T; Frittitta L; Castellino P; Purrello F; Piro S; Di Pino A
    Cardiovasc Diabetol; 2023 Dec; 22(1):344. PubMed ID: 38093293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albuminuric and non-albuminuric reduced eGFR phenotypes in youth with type 1 diabetes: Factors associated with cardiometabolic risk.
    Di Bonito P; Mozzillo E; Rosanio FM; Maltoni G; Piona CA; Franceschi R; Ripoli C; Ricciardi MR; Tornese G; Arnaldi C; Iovane B; Iafusco D; Zanfardino A; Suprani T; Savastio S; Cherubini V; Tiberi V; Piccinno E; Schiaffini R; Delvecchio M; Casertano A; Maffeis C; Franzese A;
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2033-2041. PubMed ID: 34083127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Markers of Tubular Injury and Renal Fibrosis in Patients with Type 2 Diabetes and Different Phenotypes of Chronic Kidney Disease.
    Korbut AI; Romanov VV; Klimontov VV
    Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus.
    Boronat M; García-Cantón C; Quevedo V; Lorenzo DL; López-Ríos L; Batista F; Riaño M; Saavedra P; Checa MD
    Ren Fail; 2014 Mar; 36(2):166-70. PubMed ID: 24059817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality.
    Garofolo M; Russo E; Miccoli R; Lucchesi D; Giusti L; Sancho-Bornez V; Daniele G; Del Prato S; Penno G
    J Diabetes Complications; 2018 Jun; 32(6):550-557. PubMed ID: 29705091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cross-Sectional Study for Prevalence and Association of Risk Factors of Chronic Kidney Disease Among People With Type 2 Diabetes in the Indian Setting.
    Tewari A; Tewari V; Tewari J
    Cureus; 2021 Sep; 13(9):e18371. PubMed ID: 34725618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuric and non-albuminuric patterns of chronic kidney disease in type 2 diabetes.
    Klimontov VV; Korbut AI
    Diabetes Metab Syndr; 2019; 13(1):474-479. PubMed ID: 30641747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.
    Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Lamacchia O; Scardapane M; Nicolucci A; Pugliese G;
    Diabetologia; 2018 Nov; 61(11):2277-2289. PubMed ID: 30032426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency.
    Yamamoto Y; Hanai K; Mori T; Yokoyama Y; Yoshida N; Murata H; Shinozaki T; Babazono T
    Diabetologia; 2022 Jan; 65(1):234-245. PubMed ID: 34739552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease.
    Korbut AI; Romanov VV; Klimontov VV
    Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetes.
    Buyadaa O; Salim A; Morton JI; Jandeleit-Dahm K; Magliano DJ; Shaw JE
    Ther Adv Endocrinol Metab; 2022; 13():20420188221083518. PubMed ID: 35355954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum angiopoietin-2: a promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes.
    Salem NA; Ismail WM; Hendawy SR; Abdelrahman AM; El-Refaey AM
    Eur J Pediatr; 2024 Jun; ():. PubMed ID: 38884820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion.
    Chang JH; Paik SY; Mao L; Eisner W; Flannery PJ; Wang L; Tang Y; Mattocks N; Hadjadj S; Goujon JM; Ruiz P; Gurley SB; Spurney RF
    PLoS One; 2012; 7(4):e33942. PubMed ID: 22496773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.